...
首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
【24h】

Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.

机译:国际儿科肿瘤学会/英国儿童癌症研究小组PNET-3对M0-M1髓母细胞瘤放疗前化疗的放疗参数对预后的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To analyze the impact of radiotherapy (RT) parameters on outcome in a randomized study of pre-RT chemotherapy for M0-M1 medulloblastoma. METHODS AND MATERIALS: Patients were randomized to RT alone or RT preceded by chemotherapy with vincristine, etoposide, carboplatin, and cyclophosphamide. RT consisted of craniospinal RT, 35 Gy in 21 fractions, followed by a posterior fossa (PF) boost of 20 Gy in 12 fractions. The accuracy of cribriform fossa, skull base, and PF field placement was assessed. RESULTS: Between 1992 and 2000, 217 patients were randomized, of whom 179 were eligible for analysis. At a median follow-up of 5.4 years, the 3- and 5-year overall survival rate was 79.5% and 70.7%, respectively. The 3- and 5-year event-free survival (EFS) rate was 71.6% and 67.0%, respectively. EFS was significantly better for the chemotherapy plus RT group (3-year EFS rate 78.5% vs. 64.8%, p = 0.0366). Overall survival and EFS were significantly better for patients completing RT within 50 days compared with those taking >50 days to complete RT (3-year overall survival rate 84.1% vs. 70.9%, p = 0.0356, 3-year EFS rate 78.5% vs. 53.7%, p = 0.0092). Multivariate analysis identified the use of chemotherapy (p = 0.0248) and RT duration (p = 0.0100) as predictive of better EFS. Planning films were reviewed for 131 (74.4%) of 176 patients. Sixty-five (49.6%) had no targeting deviations and 58 (44.3%) had one or more deviations. PF recurrence occurred in 11 (34.4%) of 32 with a PF targeting deviation compared with 13 (16.3%) of 80 without (p = 0.043). No statistically significant impact of other targeting deviations on recurrence risk or EFS were found. CONCLUSION: The results of this study have confirmed the importance of the duration of RT for medulloblastoma. Also, attention to detail when planning RT is important, as illustrated in the case of PF field placement.
机译:目的:在一项针对M0-M1髓母细胞瘤的放疗前化疗的随机研究中,分析放疗(RT)参数对预后的影响。方法和材料:将患者随机分为单纯接受放疗或接受长春新碱,依托泊苷,卡铂和环磷酰胺化疗的患者。 RT包括颅骨RT,分为21个分数,分别为35 Gy,然后是12个分数的后颅窝(PF)增强20 Gy。评估了筛状窝,颅底和PF区域放置的准确性。结果:从1992年到2000年,共有217例患者被随机分组​​,其中179例符合分析条件。在5.4年的中位随访中,3年和5年总生存率分别为79.5%和70.7%。 3年和5年无事件生存率(EFS)分别为71.6%和67.0%。化疗加放疗组的EFS明显更好(3年EFS率分别为78.5%和64.8%,p = 0.0366)。与在50天内完成RT的患者相比,在50天内完成RT的患者的总生存率和EFS显着更好(3年总生存率84.1%对70.9%,p = 0.0356,3年EFS率78.5%对53.7%,p = 0.0092)。多变量分析确定了化疗(p = 0.0248)和放疗持续时间(p = 0.0100)的使用可预示更好的EFS。对176例患者中的131例(74.4%)的计划电影进行了审查。六十五(49.6%)没有目标偏差,而58(44.3%)有一个或多个偏差。 PF复发的32例中有11例(34.4%)发生了PF定位偏差,而80例中的13例(16.3%)发生了PF复发(p = 0.043)。没有发现其他靶向偏差对复发风险或EFS的统计学显着影响。结论:这项研究的结果证实了放疗持续时间对髓母细胞瘤的重要性。同样,在计划RT时,注意细节也很重要,如PF现场放置的情况所示。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号